Ordering
Available Variants100 mg
CHA.68974-100mg
Price
€208.80
Available – Dispatch in 14 days
1 g
CHA.68974-1g
Price
€46.16
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.68974-100mg | €208.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHA.68974-1g | €46.16 |
calcium channel blocker, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C24H34N2O · HCl |
|---|---|
| CAS Number | 68099-86-5 |
| Molecular Weight | 403.00 |
| UNSPSC Code | 12352202 |
| PubChem Substance ID | 24277824 |
| NACRES | NA.77 |
| MDL number | MFCD00065498 |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Bepridil hydrochloride, with a chemical formula of C24H33NO3.HCl and a CAS number of 69286-06-2, is a calcium channel blocker that has been utilized in the management of angina pectoris. It functions by inhibiting the influx of calcium ions into cardiac and vascular smooth muscle cells, thereby reducing myocardial oxygen demand and promoting vasodilation. Bepridil hydrochloride exhibits a unique pharmacological profile, possessing additional properties such as antiarrhythmic and beta-adrenergic blocking activities. Its therapeutic effects are attributed to its ability to modulate various ion channels and receptors, resulting in improved cardiac function and reduced symptoms of angina. As a result, bepridil hydrochloride has been employed as a valuable therapeutic agent in the treatment of cardiovascular diseases, particularly in patients with stable angina. Its efficacy and safety have been evaluated in numerous clinical trials.
